PQA Endorses New Performance Measures To Address Opioid Misuse/Abuse

Tori-120x120

Unsafe opioid use leads to nearly 100,000 ER visits every year. RxAnte collaborated with PQA, Aetna, and Wellcare to devise new performance measures to help ensure proper opioid use.

Learn more about RxAnte’s role in the development of these measures here.

Related Resources

04-02-2026

RxAnte Recognized by the Financial Times as One of the Americas’ Fastest-Growing Companies for the Second Consecutive Year

read more

03-18-2026

RxAnte Named One of New England’s Fastest-Growing Companies for the Second Consecutive Year 

read more

01-13-2026

RxAnte Announces Strategic Growth Investment from Primus Capital

read more